Dr. Jyostna Deepika Pulla, MD

Dr. Pulla practices at Atrium Health Cabarrus in Concord, North Carolina, part of Advocate Health.

Dr. Pulla's NPI, 1114274586, was assigned on August 5, 2012. Dr. Pulla holds Michigan license 4301100546.

Dr. Pulla's primary practice is Atrium Health Cabarrus, at 920 Church St N, Concord, NC 28025 in Cabarrus County. The practice phone is (704) 783-3000.

Dr. Pulla's primary practice is Atrium Health Cabarrus in Concord, North Carolina, part of Advocate Health. Dr. Pulla is also affiliated with Atrium Health Carolinas Medical Center. The medical group on file is Atrium Health Cleveland Imaging. Dmand AI also links Dr. Pulla to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pulla practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Pulla's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Pulla is licensed in Michigan.

CMS data shows 208 Medicare services from Dr. Pulla across 2 procedure codes in 2024, for 100 Medicare patients. Medicare paid $18,769 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 100 Medicare patients who saw Dr. Pulla in 2024. The largest group is 75 to 84, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pulla's median patient age at 77, with 51% women.

In 2024, Dr. Pulla wrote 105 Medicare Part D claims for 51 patients. 89% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $31 in total drug cost. In 2021, CMS named 62 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Pulla for performance year 2024, reported through an alternative payment model (APM). Dr. Pulla accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Dr. Pulla from 3 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $20.